Swaroopa Guda is an analytical development and CMC expert specializing in bioanalytical methods and gene therapies targeting hematopoietic stem cells. They have held numerous positions, including Director of Analytical Development at Thymmune Therapeutics and previously at Garuda Therapeutics, and contributed significantly to the advancement of lentiviral vector applications in clinical settings. With a Ph.D. in Biotechnology, Swaroopa has developed and optimized various therapeutic vectors, focusing on conditions like sickle cell disease. Their leadership in cross-functional teams has enhanced the capabilities in process and analytical development across several biotech firms.
This person is not in any teams
This person is not in any offices